These biotech companies have catalysts ahead.

Makary pointed to three bottlenecks: hospital contracting; ethical reviews and approvals; and the Investigational New Drug applications process ...

Whisper it, but we may finally be seeing the IPO window reopening in 2026. | Whisper it, but we may finally be seeing the IPO window reopening in 2026.

Unnatural Products is proving to be a natural at securing partnerships, this time linking up with Novartis in a deal that could garner up to $1.7 billion in biobucks.

A robot at work inside CMU's Biological and Chemical Innovation Cloud Lab. GIF: Ryan Deto/Axios Pittsburgh's biotech industry is ahead of the curve, according to the National Security Commission on ...

Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...

Well, investors at Fairmount, Venrock, Wellington Management, and TCGX believe so. They and other firms have handed $175 ...

Wall Street analysts are placing aggressive bets on four clinical-stage biotech companies, with consensus price targets implying gains of up to 384%. These pre-revenue or early-revenue firms carry ...

AI search is fundamentally changing how consumers navigate decision making, and brands must adapt in order to be discoverable.

Feed additives suit intensive farms but different solutions for methane reduction are needed for pasture-raised cattle, says ...

Commissioner Dov Zakheim called the under-construction BioForge facility a model for national expansion. The tour also included Carnegie Mellon University's AI-powered cloud lab. Local biotech firm ...

Celebrate International Day of Women and Girls in Science 2026 by discovering some of the most influential women shaping biotech today.